Avalo Therapeutics (AVTX) Treasury Shares (2014 - 2026)
Avalo Therapeutics' (AVTX) quarterly Treasury Shares came in at $190203.0 in Q1 2026, up 9510050.0% YoY from N/an in Q1 2025, and down 50.86% on a QoQ basis from $387064.0 in Q4 2025.
Avalo Therapeutics (AVTX) Treasury Shares (2014 - 2026) Analysis & Trends
Avalo Therapeutics (AVTX) has 11 years of Treasury Shares data on file, last reported at $190203.0 in Q1 2026.
- Quarterly Treasury Shares rose 9510050.0% year-over-year to $190203.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $190203.0 (up 9510050.0% YoY) and the FY2025 annual result came in at $387064.0, up 19353100.0% from the prior year.
- Treasury Shares eased to $190203.0 in Q1 2026, from $387064.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $421397.0 in Q3 2025 to a low of $2.0 in Q4 2024.
- A 4-year average of $106835.2 and a median of $18036.0 in 2024 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 19353100.0% in 2025, down 99.99% in 2025.
- Tracing AVTX's Treasury Shares over 4 years: stood at $11250.0 in 2022, then plunged by 99.98% to $2.0 in 2024, then jumped by 19353100.0% to $387064.0 in 2025, then slumped by 50.86% to $190203.0 in 2026.
- The last three Treasury Shares figures came in at $190203.0 (Q1 2026), $387064.0 (Q4 2025), and $421397.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | 183,869.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 183,869.00 |
| Jun 30, 2026 | 183,869.00 |
| Mar 31, 2026 | 190,203.00 |
| Mar 31, 2026 | 190,203.00 |
| Dec 31, 2025 | 387,064.00 |
| Dec 31, 2025 | 387,064.00 |
| Sep 30, 2025 | 421,397.00 |
| Sep 30, 2025 | 421,397.00 |
| Jun 30, 2025 | 2.00 |
| Jun 30, 2025 | 2.00 |
| Mar 31, 2025 | 2.00 |
| Mar 31, 2025 | 2.00 |
| Dec 31, 2024 | 2.00 |
| Dec 31, 2024 | 2.00 |
| Sep 30, 2024 | 13,712.00 |
| Sep 30, 2024 | 13,712.00 |
| Jun 30, 2024 | 22,360.00 |
| Jun 30, 2024 | 22,360.00 |
| Mar 31, 2024 | 22,360.00 |
| Mar 31, 2024 | 22,360.00 |